Bipin Sethi, K. D. Modi, K. Srikanth, S. Erande, K. Khaladkar, Manoj Kumar, Sumit Bhushan, S. Suryawanshi, H. Barkate
{"title":"一项评估瑞格列净与达格列净在持续血糖监测下对血糖变异性影响的前瞻性多中心开放标签研究(REMIT - GV研究)","authors":"Bipin Sethi, K. D. Modi, K. Srikanth, S. Erande, K. Khaladkar, Manoj Kumar, Sumit Bhushan, S. Suryawanshi, H. Barkate","doi":"10.29011/2574-7568.001099","DOIUrl":null,"url":null,"abstract":"A Prospective Multicenter Open-label Study to Assess Effect of Remogliflozin on Glycemic Variability Compared to Dapagliflozin Using Continuous Glucose Monitoring (REMIT - GV study)","PeriodicalId":73707,"journal":{"name":"Journal of diabetes and treatment","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Prospective Multicenter Open-label Study to Assess Effect of Remogliflozin on Glycemic Variability Compared to Dapagliflozin Using Continuous Glucose Monitoring (REMIT - GV study)\",\"authors\":\"Bipin Sethi, K. D. Modi, K. Srikanth, S. Erande, K. Khaladkar, Manoj Kumar, Sumit Bhushan, S. Suryawanshi, H. Barkate\",\"doi\":\"10.29011/2574-7568.001099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A Prospective Multicenter Open-label Study to Assess Effect of Remogliflozin on Glycemic Variability Compared to Dapagliflozin Using Continuous Glucose Monitoring (REMIT - GV study)\",\"PeriodicalId\":73707,\"journal\":{\"name\":\"Journal of diabetes and treatment\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of diabetes and treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2574-7568.001099\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes and treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2574-7568.001099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Prospective Multicenter Open-label Study to Assess Effect of Remogliflozin on Glycemic Variability Compared to Dapagliflozin Using Continuous Glucose Monitoring (REMIT - GV study)
A Prospective Multicenter Open-label Study to Assess Effect of Remogliflozin on Glycemic Variability Compared to Dapagliflozin Using Continuous Glucose Monitoring (REMIT - GV study)
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
